scholarly journals Encapsulation of Micro- and Milli-Sized Particles with a Hollow-Type Spherical Bacterial Cellulose Gel via Particle-Preloaded Droplet Cultivation

2019 ◽  
Vol 20 (19) ◽  
pp. 4919 ◽  
Author(s):  
Toru Hoshi ◽  
Masashige Suzuki ◽  
Mayu Ishikawa ◽  
Masahito Endo ◽  
Takao Aoyagi

A hollow-type spherical bacterial cellulose (HSBC) gel prepared using conventional methods cannot load particles larger than the pore size of the cellulose nanofiber network of bacterial cellulose (BC) gelatinous membranes. In this study, we prepared a HSBC gel encapsulating target substances larger than the pore size of the BC gelatinous membranes using two encapsulating methods. The first method involved producing the BC gelatinous membrane on the surface of the core that was a spherical alginate gel with a diameter of 2 to 3 mm containing the target substances. With this method, the BC gelatinous membrane was biosynthesized using Gluconacetobacter xylinus at the interface between the cell suspension attached onto the alginate gel and the silicone oil. The second method involved producing the BC gel membrane on the interface between the silicone oil and cell suspension, as well as the spherical alginate gel with a diameter of about 1 mm containing target substances. After the BC gelatinous membrane was biosynthesized, an alginate gel was dissolved in a phosphate buffer to prepare an HSBC gel with the target substances. These encapsulated substances could neither pass through the BC gelatinous membrane of the HSBC gel nor leak from the interior space of the HSBC gel. These results suggest that the HSBC gel had a molecular sieving function. The HSBC gel walls prepared using these methods were observed to be uniform and would be useful for encapsulating bioactive molecules, such as immobilized enzymes in HSBC gel, which is expected to be used as a drug carrier.

Pharmaceutics ◽  
2020 ◽  
Vol 12 (11) ◽  
pp. 1076
Author(s):  
Toru Hoshi ◽  
Masahito Endo ◽  
Aya Hirai ◽  
Masashige Suzuki ◽  
Takao Aoyagi

For reducing side effects and improvement of swallowing, we studied the encapsulation of activated carbon formulations with a hollow-type spherical bacterial cellulose (HSBC) gel using two kinds of encapsulating methods: Methods A and B. In Method A, the BC gelatinous membrane was biosynthesized using Komagataeibacter xylinus (K. xylinus) at the interface between the silicone oil and cell suspension containing activated carbon. In Method B, the bacterial cellulose (BC) gelatinous membrane was formed at the interface between the cell suspension attached to the alginate gel containing activated carbon and the silicone oil. After the BC gelatinous membrane was biosynthesized by K. xylnus, alginate gel was removed by soaking in a phosphate buffer. The activated carbon encapsulated these methods could neither pass through the BC gelatinous membrane of the HSBC gel nor leak from the interior cavity of the HSBC gel. The adsorption ability was evaluated using indole, which is a precursor of the uremic causative agent. From curve-fitting, the adsorption process followed the pseudo-first-order and intra-particle diffusion models, and the diffusion of the indole molecules at the surface of the encapsulated activated carbon within the HSBC gel was dominant at the initial stage of adsorption. It was observed that the adsorption of the encapsulated activated carbon by the intraparticle diffusion process became dominant with longer adsorption times.


2001 ◽  
Vol 34 (12) ◽  
pp. 1524-1531 ◽  
Author(s):  
TAKAAKI TANAKA ◽  
YOSHINOBU YAMAGIWA ◽  
TETSUYA NAGANO ◽  
MASAYUKI TANIGUCHI ◽  
KAZUHIRO NAKANISHI

2018 ◽  
Vol 1 (1) ◽  
pp. 42-50 ◽  
Author(s):  
Xiao Chen ◽  
Xuran Xu ◽  
Wenping Li ◽  
Bianjing Sun ◽  
Jun Yan ◽  
...  

2020 ◽  
Vol 248 ◽  
pp. 116745
Author(s):  
Sergey O. Solomevich ◽  
Egor I. Dmitruk ◽  
Pavel M. Bychkovsky ◽  
Alexander E. Nebytov ◽  
Tatiana L. Yurkshtovich ◽  
...  

2000 ◽  
Vol 12 (11) ◽  
pp. 3301-3305 ◽  
Author(s):  
Haruo Takahashi ◽  
Bo Li ◽  
Toshiya Sasaki ◽  
Chie Miyazaki ◽  
Tsutomu Kajino ◽  
...  

2009 ◽  
Vol 41 (9) ◽  
pp. 764-770 ◽  
Author(s):  
Ananda Putra ◽  
Akira Kakugo ◽  
Hidemitsu Furukawa ◽  
Jian Ping Gong

2018 ◽  
Vol 30 (05) ◽  
pp. 1850031
Author(s):  
Parastoo Namdarian ◽  
Ali Zamanian ◽  
Azadeh Asefnejad ◽  
Maryam Saeidifar

In recent years, the strategy of using microspheres as drug carrier system has been very much considered. Also the use of natural polymers for pharmaceutical applications is very attractive. Given that various polymer materials are available for making microspheres, there is an active research to develop new, safe and effective release for microspheres. Olibanum is used as a drug carrier in this study. Also dexamethasone (DEX) is one of the commonly bioactive molecules used in bone tissue engineering. In this research, the purification and characterization of olibanum were first studied by FTIR, XRD, pH determination and MTT test. Due to its non-toxicity, biocompatibility, availability and biodegradability, this material can be a good choice as a natural polymer. Then the microspheres were synthesized with single emulsion method and studied by SEM and FTIR. The morphology and structure of the microspheres revealed that they are spherical and separate, which have rough and porous surface. Also the release mechanism of drug from olibanum microspheres was determined in accordance with the different kinetic drug release models. Investigating the drugs release behavior and degradation rate of microspheres revealed that they were suitable for dexamethasone-controlled release and can be used well in tissue engineering scaffolds.


2009 ◽  
Vol 24 (2) ◽  
pp. 107-111 ◽  
Author(s):  
Masoom Yasinzai

Cancer patients are found to have elevated serum levels of lipid-associated sialic acid (LASA). LASA measurement provides a valuable test for the diagnosis of human cancer. The currently used measurement methods are tedious and nonselective. Here we report a method based on immobilized enzyme minicolumns in a flow system for the analysis of this clinically important analyte. Three enzymes comprising two minicolumns are introduced online and the analyte in a precisely injected volume of 20 μL is made to pass through these immobilized enzyme columns. The final product of the reaction is detected amperometrically. Neuraminidase and NANA-aldolase are coimmobilized on controlled pore glass, followed by a column of pyruvate oxidase. The method was applied to the quantitation of LASA in the sera of normal individuals and patients with cancer of the esophagus. We observed no loss of activity of the immobilized enzymes after analyzing about 300 samples. The sample throughput was 30 samples per hour.


2020 ◽  
Vol 26 (27) ◽  
pp. 3300-3316
Author(s):  
Pragya Sharma ◽  
Surbhi Dhawan ◽  
Sanju Nanda

: Cubosome is a biocompatible, thermodynamically stable and bioadhesive drug carrier that is prepared from certain amphiphilic lipids and surfactants when mixed in a definite ratio. Structurally, they are selfassembled nano-constructed liquid crystalline particles comprising three-dimensionally arranged bicontinuous as well as nonintersecting lipid bilayers that give them a honeycomb-like appearance. Morphological characterization through SAXS (small-angle X-ray scattering) and cryo-TEM (cryo-transmission electron microscopy) revealed that they are square and round shaped particles in the nanometer range. These carriers have two separate aqueous regions and a large interfacial area that allow them to carry a variety of bioactive molecules having hydrophobic, hydrophilic or amphiphilic behavior. : One of either two strategies i.e., top-down or bottom-up methods can be adopted to prepare these cubic structures. A number of dispersion techniques like sonication, spray drying, high-pressure homogenization or spontaneous emulsification can be adopted to prepare cubosomes. Their characteristics and benefits like multicompartmental structure, high drug loading, simple and convenient method of preparation, use of biodegradable lipids such as glycerol monooleate, encapsulation of hydrophilic, hydrophobic and amphiphilic moieties, targeted and controlled release make them versatile bioactive carriers that can be administered through multiple biological routes like topical, transdermal, parenteral, and oral. Cubosomes have appreciable applications in various fields especially in the pharmaceutical industry where they are used as potential bioactive carriers. Molecules like paclitaxel, oligonucleotide, δ-amino-levulinic acid, bovine serum albumin, etc. can be easily delivered through this system. : This article provides a detailed note on the structure of cubosomes, ingredients and techniques used for their preparation, mechanism of drug release, applications and routes of drug administration, their formulations, patent review and market scenario.


2019 ◽  
Vol 4 (3) ◽  
pp. 667-673 ◽  
Author(s):  
Gregory S. Hutchings ◽  
Eric I. Altman

Stretching two-dimensional GaPO4 causes its GaO4 and PO4 building blocks to counter-rotate allowing its pore size to be dynamically tuned to allow specific molecules to pass through.


Sign in / Sign up

Export Citation Format

Share Document